Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Rob Jones

- PMLiVE

Cytokinetics to discontinue ALS drug candidate following phase 3 trial failure

The neurodegenerative disease affects approximately 27,000 people in the US

- PMLiVE

Novo Nordisk’s weight-loss drug recommended by CHMP for adolescents

Semaglutide works by mimicking an intestinal hormone that is released after eating

- PMLiVE

Making the most of our valued talent pool

Encouraging people who are returning to work after a career break to see it as a positive experience

- PMLiVE

Origins’ Knowledge Centre

A collection of resources including webinar recordings, publications and short videos to help you be more patient focussed

Origins – The Patient Focused Specialists

- PMLiVE

Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD

The common inflammatory skin disease affects over 4% of adults in the EU

- PMLiVE

Bristol Myers Squibb’s Sotyktu approved by EC for plaque psoriasis

At least 100 million people worldwide are impacted by some form of psoriasis

- PMLiVE

When to call in the specialists: strategy in Medical Affairs

By Laura Wilson

- PMLiVE

Time to talk about health inequalities

Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.To find out more about Impetus: https://www.meetwithimpetus.comImpetus Digital...

Impetus Digital

- PMLiVE

AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma

An estimated 98,000 patients with severe uncontrolled asthma may be eligible for the new treatment

- PMLiVE

Healthware Group report on depression care in Italy highlights need for digital therapeutics

Mental health disorders are the fifth leading cause of disability adjusted life years in Italy

- PMLiVE

Masking the truth

Why a not-so-good editorial piece from The New York Times has me a little vexed

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links